How Does First Line Treatment With DSLT Perform in Treatment-naïve Patients With Newly Diagnosed Primary Open Angle Glaucoma
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 30
Healthy Volunteers: f
View:
• Primary open angle glaucoma
• Patients age 30 or greater with an IOP of 18-26 mmHg
• Mild to moderate POAG patients (mild or moderate according to the AAO PPP Guidelines)
• DSLT procedure
Locations
United States
Arizona
Barnet Dulaney Perkins Eye Centers
RECRUITING
Mesa
Contact Information
Primary
Derek J Arnson, Master of Education
derek.arnson@researchavp.com
4804201005
Backup
Christine Funke, Medical Doctor
christine.funke@BDPEC.com
4804201005
Time Frame
Start Date: 2025-03-31
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 55
Treatments
Treatment naïve (including medication in either eye, previous laser or surgery) mild to moderate POA
(including medication in either eye, previous laser or surgery) mild to moderate POA
Related Therapeutic Areas
Sponsors
Collaborators: Alcon, a Novartis Company
Leads: Barnet Dulaney Perkins Eye Centers